Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Natalia Buenache
Observed names:
N. Buenache,
N. Buenache Cuenda,
Natalia Buenache Cuenda
Institution:
Hospital Universitario 12 De Octubre
Observed institutions:
Universidad Complutense de Madrid,
Research Institute Hospital 12 de Octubre,
Spanish National Cancer Research Centre,
Hospital Universitario 12 De Octubre
ORCID:
0009-0009-9145-3462
Observed ORCID:
0009-0009-9145-3462
OpenAlex ID:
A5072328149
Making clinical decisions based on measurable residual disease improves the outcome in multiple myeloma
2021
·
Joaquin Martinez-Lopez
, Rafael Alonso
, et al.
·
Journal of Hematology & Oncology
·
39
PDF
NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical Trial
2022
·
Juan Manuel Rosa-Rosa
, Isabel Cuenca
, et al.
·
Cancers
·
19
PDF
Genetic Alterations in Members of the Proteasome 26S Subunit, AAA-ATPase (PSMC) Gene Family in the Light of Proteasome Inhibitor Resistance in Multiple Myeloma
2023
·
Larissa Haertle
, Natalia Buenache
, et al.
·
Cancers
·
14
PDF
Epigenetic Modifications As a Mechanism of Resistance to BCMA-Directed Immunotherapies in Multiple Myeloma: Insights from Multi-Omic Profiling
2024
·
Larissa Haertle
, Natalia Buenache Cuenda
, et al.
·
Blood
·
8
Clonal competition assays identify fitness signatures in cancer progression and resistance in multiple myeloma
2024
·
Larissa Haertle
, Umair Munawar
, et al.
·
HemaSphere
·
7
Minimally Invasive Assessment of Measurable Residual Disease (MRD) in Multiple Myeloma (MM)
2023
·
Carmen Gonzalez
, Marta Lasa
, et al.
·
Blood
·
7
Minimally invasive characterization of peripheral blood measurable residual disease in multiple myeloma using high‐sensitivity detection of ctDNA by next‐generation sequencing
2026
·
Natalia Buenache
, Marta Lasa
, et al.
·
HemaSphere
·
2
Multi-Omic Profiling Reveals Epigenetic Drivers of Immunotherapy Resistance in Multiple Myeloma
2025
·
Larissa Haertle
, Natalia Buenache Cuenda
, et al.
·
medRxiv
·
2
PDF
Identification of Immunoglobulin Gene Rearrangement Biomarkers in Multiple Myeloma through cfDNA-Based Liquid Biopsy Using tchDNA-Seq
2023
·
Natalia Buenache
, Andrea Sánchez-delaCruz
, et al.
·
Cancers
·
2
PDF
Comprehensive DNA/RNA-based targeted sequencing for molecular karyotyping and clonality assessment in newly diagnosed multiple myeloma patients
2025
·
Juan Manuel Rosa-Rosa
, Natalia Buenache
, et al.
·
Blood
Minimally invasive assessment of peripheral residual disease (PRD) during maintenance or observation in patients (Pts) with multiple myeloma (MM): An update from the GEM2017FIT clinical trial
2025
·
Carmen Gonzalez
, Marta Lasa
, et al.
·
Blood
825P Ultra-sensitive cfDNA analysis for minimally invasive measurable residual disease detection and profiling in multiple myeloma
2024
·
N. Buenache
, A. Martín-Muñoz
, et al.
·
Annals of Oncology
P-165 Advanced circulating tumor DNA (ctDNA) Profiling: Enhancing Non-Invasive Detection and Characterization of Measurable Residual Disease (MRD) in Multiple Myeloma (MM)
2024
·
Natalia Buenache
, Alejandro Martín-Muñoz
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Intracytoplasmatic BCMA Point Mutation and Teclistamab Resistance: Genomic Assessment of a Multidrug-Resistant Multiple Myeloma Patient
2023
·
Natalia Buenache Cuenda
, Hipolito Nicolas Cuesta Hernández
, et al.
·
Blood
PDF
P840: Assessment of Conventional Translocations and Ig Rearrangements in the Diagnosis of Multiple Myeloma Patients Using a Targeted Capture-hybridization Rna Sequencing Panel.
2023
·
Natalia Buenache Cuenda
, Ricardo Sánchez
, et al.
·
HemaSphere
P845: Identification of Multiple Myeloma Biomarkers Via Liquid Biopsy Based on Cell-free Dna Using a Capture-hybridization Panel
2022
·
N. Buenache Cuenda
, A. Sánchez-delaCruz
, et al.
·
HemaSphere
Actividad de Dalbavancina frente a los biofilms formados por diferentes fenotipos de MRSA y MRSE
2018
·
Natalia Buenache Cuenda
·
Biólogos: Revista del Colegio Oficial de Biólogos de la Comunidad de Madrid
Show more works
View as search
Works count:
17
Citation count:
103
H-index:
6
I10-index:
3
Year
Topic
Type